Adapt Investment Managers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,873
Closed -$16.2M 145
2026
Q1
$14.6M Buy
+15,873
New +$16.1M 0.19% 86
2025
Q4
Sell
-199
Closed -$190K 155
2025
Q3
$152K Buy
+199
New +$148K ﹤0.01% 124

Other funds holding LLY

Adapt Investment Managers's LLY Position: Q2 2026 in Review

Adapt Investment Managers sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 15,873 shares — an estimated $16.2M sold.

Adapt Investment Managers first reported a position in LLY in Q3 2025 and held it in 2 quarters. The position peaked at $14.6M in Q1 2026. 1,691 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Adapt Investment Managers reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Adapt Investment Managers sold 15,873 Eli Lilly shares in Q2 2026, an estimated $16.2M.
  • Adapt Investment Managers first reported a position in Eli Lilly in Q3 2025 and held it in 2 quarters.
  • Adapt Investment Managers's Eli Lilly position peaked at $14.6M in Q1 2026.
  • 1,691 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Adapt Investment Managers's 13F filing for Q2 2026, filed 27 Jul 2026.